TAK-632
>98%
- Product Code: 102747
CAS:
1228591-30-7
| Molecular Weight: | 554.52 g./mol | Molecular Formula: | C₂₇H₁₈F₄N₄O₃S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
TAK-632 is primarily used in research settings as a potent and selective inhibitor of BRAF kinase, a key protein involved in the MAPK/ERK signaling pathway. This pathway is often dysregulated in various cancers, particularly melanoma. By inhibiting BRAF kinase, TAK-632 helps researchers study the effects of blocking this pathway on cancer cell growth, proliferation, and survival. It is particularly valuable in understanding the mechanisms of resistance to other BRAF inhibitors and in developing new therapeutic strategies for BRAF-mutant cancers. Additionally, TAK-632 is utilized in preclinical studies to evaluate its potential efficacy and safety as a targeted cancer therapy.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Yellow Solid |
| Purity (%) | 98-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | $261.18 |
+
-
|
| 0.050 | 10-20 days | $984.43 |
+
-
|
| 0.100 | 10-20 days | $1,451.53 |
+
-
|
TAK-632
TAK-632 is primarily used in research settings as a potent and selective inhibitor of BRAF kinase, a key protein involved in the MAPK/ERK signaling pathway. This pathway is often dysregulated in various cancers, particularly melanoma. By inhibiting BRAF kinase, TAK-632 helps researchers study the effects of blocking this pathway on cancer cell growth, proliferation, and survival. It is particularly valuable in understanding the mechanisms of resistance to other BRAF inhibitors and in developing new therapeutic strategies for BRAF-mutant cancers. Additionally, TAK-632 is utilized in preclinical studies to evaluate its potential efficacy and safety as a targeted cancer therapy.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :